Clinical Trial Update: Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)

View source ↗

Summary

A completed clinical trial in Sweden evaluated the safety of etoricoxib (MK-0663) in patients with spondyloarthropathies, including ankylosing spondylitis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Spondyloarthropathies

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Spondylarthropathies; Spondylitis, Ankylosing | Status: COMPLETED